有些超级吃货能帮助医生治病
Everybody poops, but some people's excrement is objectively better. Somewhere in the crowd are a few people who pass peerless poops, powerful enough to potentially treat inflammatory bowel disease (IBD) and type 2 diabetes. A massive analysis of faecal transplant research has now driven these exceptional donors out of the cubicles and into the spotlight. Trial after trial, researchers from the University of Auckland were able to pin the medal of remission on a single donor, whose stool was filled to the brim with all the best and most necessary bacteria. "The pattern of success in these trials demonstrates the existence of 'super-donors', whose stool is particularly likely to influence the host gut and to lead to clinical improvement," explains senior author Justin O'Sullivan, who studies how the microbiome can inform the treatment of complex disorders at the University of Auckland. "We see transplants from super-donors achieve clinical remission rates of perhaps double the remaining average." The idea of super poopers has long been suspected, but this is one of the first overarching studies to substantiate their existence. Past research has shown that passing poop from one individual to another is a reliable treatment for serious, recurrent infections of the gut, no matter who the donor is. Yet for some reason, when it comes to treating IBD and type 2 diabetes, faecal transplants appear to work less than a quarter of the time. |